The Middle East Atelosteogenesis Treatment Market is showing promising growth, driven by rising awareness of genetic disorders and steady improvements in healthcare systems across the region. Valued at USD 0.15 billion in 2024, the market is expected to reach USD 0.45 billion by 2034, growing at a compound annual growth rate (CAGR) of 11.5% during the forecast period. This growth is...